Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): What are the real risks?

Prud'homme C, Deschamps F, Allorant A, Massard C, Hollebecque A, Yevich S, Ngo-Camus M, Gravel G, Nicotra C, Michiels S, Scoazec JY, Lacroix L, Solary E, Soria JC, De Baere T, Tselikas L.

Eur J Cancer. 2018 Sep 14;103:108-119. doi: 10.1016/j.ejca.2018.08.003. [Epub ahead of print]

PMID:
30223224
2.

Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.

Palussière J, Chomy F, Savina M, Deschamps F, Gaubert JY, Renault A, Bonnefoy O, Laurent F, Meunier C, Bellera C, Mathoulin-Pelissier S, de Baere T.

J Cardiothorac Surg. 2018 Aug 24;13(1):91. doi: 10.1186/s13019-018-0773-y.

3.

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).

Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.

BMC Cancer. 2018 Aug 6;18(1):787. doi: 10.1186/s12885-018-4697-7.

4.

Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect?

Gelli M, Huguenin JFL, de Baere T, Benhaim L, Mariani A, Boige V, Malka D, Sourouille I, Ducreux M, Elias D, Goéré D.

Eur J Cancer. 2018 Sep;100:94-103. doi: 10.1016/j.ejca.2018.04.015. Epub 2018 Jul 5.

PMID:
30014885
5.

Interventional radiology: Role in the treatment of sarcomas.

de Baere T, Tselikas L, Gravel G, Hakime A, Deschamps F, Honoré C, Mir O, Lecesne A.

Eur J Cancer. 2018 May;94:148-155. doi: 10.1016/j.ejca.2018.02.017. Epub 2018 Mar 20. Review.

PMID:
29567631
6.

Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative.

de Baère T, Tselikas L, Deschamps F, Soria JC, Marabelle A.

Cardiovasc Intervent Radiol. 2018 Jun;41(6):825-827. doi: 10.1007/s00270-018-1935-y. No abstract available.

PMID:
29549416
7.

Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers.

Cabel L, Fuerea A, Lacroix L, Baldini C, Martin P, Hollebecque A, Postel-Vinay S, Varga A, Balheda R, Gazzah A, Michot JM, Marabelle A, Rouleau E, Solary E, De Baere T, Angevin E, Armand JP, Michiels S, Scoazec JY, Ammari S, André F, Soria JC, Massard C, Verlingue L.

Oncotarget. 2018 Jan 12;9(11):9741-9750. doi: 10.18632/oncotarget.24188. eCollection 2018 Feb 9.

8.

Pickering-Emulsion for Liver Trans-Arterial Chemo-Embolization with Oxaliplatin.

Deschamps F, Harris KR, Moine L, Li W, Tselikas L, Isoardo T, Lewandowski RJ, Paci A, Huang N, de Baere T, Salem R, Larson AC.

Cardiovasc Intervent Radiol. 2018 May;41(5):781-788. doi: 10.1007/s00270-018-1899-y. Epub 2018 Feb 21.

PMID:
29468287
9.

Corrigendum to "Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial" [Eur J Cancer 87 (2017) 122-130].

Verlingue L, Malka D, Allorant A, Massard C, Ferté C, Lacroix L, Rouleau E, Auger N, Ngo M, Nicotra C, De Baere T, Tselikas L, Ba B, Michiels S, Scoazec JY, Boige V, Ducreux M, Soria JC, Hollebecque A.

Eur J Cancer. 2018 Apr;93:156-157. doi: 10.1016/j.ejca.2018.01.077. Epub 2018 Feb 14. No abstract available.

PMID:
29454743
10.

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door.

Verlingue L, Hollebecque A, Lacroix L, Postel-Vinay S, Varga A, El Dakdouki Y, Baldini C, Balheda R, Gazzah A, Michot JM, Marabelle A, Mir O, Arnedos M, Rouleau E, Solary E, De Baere T, Angevin E, Armand JP, Michiels S, André F, Deutsch E, Scoazec JY, Soria JC, Massard C.

Eur J Cancer. 2018 Mar;92:1-10. doi: 10.1016/j.ejca.2017.12.020. Epub 2018 Feb 3.

PMID:
29413684
11.

Prevention of serious skeletal-related events by interventional radiology techniques in patients with malignant paraganglioma and pheochromocytoma.

Gravel G, Leboulleux S, Tselikas L, Fassio F, Berraf M, Berdelou A, Ba B, Hescot S, Hadoux J, Schlumberger M, Al Ghuzlan A, Nguyen F, Faron M, de Baere T, Baudin E, Deschamps F.

Endocrine. 2018 Mar;59(3):547-554. doi: 10.1007/s12020-017-1515-y. Epub 2018 Jan 5.

PMID:
29305799
12.

Intratumoral immunotherapy: using the tumor as the remedy.

Marabelle A, Tselikas L, de Baere T, Houot R.

Ann Oncol. 2017 Dec 1;28(suppl_12):xii33-xii43. doi: 10.1093/annonc/mdx683. Review.

PMID:
29253115
13.

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial.

Verlingue L, Malka D, Allorant A, Massard C, Ferté C, Lacroix L, Rouleau E, Auger N, Ngo M, Nicotra C, De Baere T, Tselikas L, Ba B, Michiels S, Scoazec JY, Boige V, Ducreux M, Soria JC, Hollebecque A.

Eur J Cancer. 2017 Dec;87:122-130. doi: 10.1016/j.ejca.2017.10.013. Epub 2017 Nov 14. Erratum in: Eur J Cancer. 2018 Feb 14;:.

PMID:
29145038
14.

Parameters for Stable Water-in-Oil Lipiodol Emulsion for Liver Trans-Arterial Chemo-Eembolization.

Deschamps F, Moine L, Isoardo T, Tselikas L, Paci A, Mir LM, Huang N, Fattal E, de Baère T.

Cardiovasc Intervent Radiol. 2017 Dec;40(12):1927-1932. doi: 10.1007/s00270-017-1763-5. Epub 2017 Aug 2.

PMID:
28770315
15.

Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients.

Hadoux J, Terroir M, Leboulleux S, Deschamps F, Al Ghuzlan A, Hescot S, Tselikas L, Borget I, Caramella C, Déandréis D, Goere D, De Baere T, Schlumberger M, Baudin E.

Horm Cancer. 2017 Dec;8(5-6):330-337. doi: 10.1007/s12672-017-0303-8. Epub 2017 Jul 26.

PMID:
28748315
16.

Update of Standard Practices for New Method Validation in Forensic Toxicology.

Wille SMR, Coucke W, De Baere T, Peters FT.

Curr Pharm Des. 2017;23(36):5442-5454. doi: 10.2174/1381612823666170714154444.

PMID:
28714407
17.

[Percutaneous lung thermo-ablation].

Palussière J, Catena V, Gaubert JY, Buy X, de Baere T.

Bull Cancer. 2017 May;104(5):417-422. doi: 10.1016/j.bulcan.2017.03.010. Epub 2017 May 3. Review. French.

PMID:
28477869
18.

High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial.

Massard C, Michiels S, Ferté C, Le Deley MC, Lacroix L, Hollebecque A, Verlingue L, Ileana E, Rosellini S, Ammari S, Ngo-Camus M, Bahleda R, Gazzah A, Varga A, Postel-Vinay S, Loriot Y, Even C, Breuskin I, Auger N, Job B, De Baere T, Deschamps F, Vielh P, Scoazec JY, Lazar V, Richon C, Ribrag V, Deutsch E, Angevin E, Vassal G, Eggermont A, André F, Soria JC.

Cancer Discov. 2017 Jun;7(6):586-595. doi: 10.1158/2159-8290.CD-16-1396. Epub 2017 Apr 1.

19.

Stabilization Improves Theranostic Properties of Lipiodol®-Based Emulsion During Liver Trans-arterial Chemo-embolization in a VX2 Rabbit Model.

Deschamps F, Farouil G, Gonzalez W, Robic C, Paci A, Mir LM, Tselikas L, de Baère T.

Cardiovasc Intervent Radiol. 2017 Jun;40(6):907-913. doi: 10.1007/s00270-017-1616-2. Epub 2017 Mar 7.

PMID:
28271329
20.

The role of image-guided therapy in the management of colorectal cancer metastatic disease.

de Baere T, Tselikas L, Yevich S, Boige V, Deschamps F, Ducreux M, Goere D, Nguyen F, Malka D.

Eur J Cancer. 2017 Apr;75:231-242. doi: 10.1016/j.ejca.2017.01.010. Epub 2017 Feb 24. Review.

PMID:
28237869
21.

A Novel Implant for the Prophylactic Treatment of Impending Pathological Fractures of the Proximal Femur: Results from a Prospective, First-in-Man Study.

Cornelis FH, Tselikas L, Carteret T, Lapuyade B, De Baere T, Cabane V, Rodrigues L, Maas C, Deschamps F.

Cardiovasc Intervent Radiol. 2017 Jul;40(7):1070-1076. doi: 10.1007/s00270-017-1613-5. Epub 2017 Feb 23.

PMID:
28233056
22.

Lung ablation: Best practice/results/response assessment/role alongside other ablative therapies.

de Baere T, Tselikas L, Gravel G, Deschamps F.

Clin Radiol. 2017 Aug;72(8):657-664. doi: 10.1016/j.crad.2017.01.005. Epub 2017 Feb 16. Review.

PMID:
28215455
23.

Percutaneous internal fixation with Y-STRUT® device to prevent both osteoporotic and pathological hip fractures: a prospective pilot study.

Cornelis FH, Tselikas L, Carteret T, Lapuyade B, De Baere T, Le Huec JC, Deschamps F.

J Orthop Surg Res. 2017 Feb 9;12(1):27. doi: 10.1186/s13018-017-0514-2.

24.

Percutaneous Thermal Ablation with Ultrasound Guidance. Fusion Imaging Guidance to Improve Conspicuity of Liver Metastasis.

Hakime A, Yevich S, Tselikas L, Deschamps F, Petrover D, De Baere T.

Cardiovasc Intervent Radiol. 2017 May;40(5):721-727. doi: 10.1007/s00270-016-1561-5. Epub 2017 Jan 4.

PMID:
28054165
25.

Percutaneous Ultrasound-Guided Carpal Tunnel Release: Study Upon Clinical Efficacy and Safety.

Petrover D, Silvera J, De Baere T, Vigan M, Hakimé A.

Cardiovasc Intervent Radiol. 2017 Apr;40(4):568-575. doi: 10.1007/s00270-016-1545-5. Epub 2016 Dec 27.

26.

First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas.

Bonvalot S, Le Pechoux C, De Baere T, Kantor G, Buy X, Stoeckle E, Terrier P, Sargos P, Coindre JM, Lassau N, Ait Sarkouh R, Dimitriu M, Borghi E, Levy L, Deutsch E, Soria JC.

Clin Cancer Res. 2017 Feb 15;23(4):908-917. doi: 10.1158/1078-0432.CCR-16-1297. Epub 2016 Oct 6.

27.

Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded).

de Baere T, Tselikas L, Boige V, Ducreux M, Malka D, Goéré D, Benahim E, Deschamps F.

Bull Cancer. 2017 May;104(5):402-406. doi: 10.1016/j.bulcan.2016.10.025. Epub 2016 Dec 16. Review.

PMID:
27993355
28.

The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.

Pagès A, Foulon S, Zou Z, Lacroix L, Lemare F, de Baère T, Massard C, Soria JC, Bonastre J.

Genet Med. 2017 Jun;19(6):683-690. doi: 10.1038/gim.2016.174. Epub 2016 Dec 1.

PMID:
27906201
29.

The IR Evolution in Oncology: Tools, Treatments, and Guidelines.

de Baere T.

Cardiovasc Intervent Radiol. 2017 Jan;40(1):3-8. doi: 10.1007/s00270-016-1503-2. Epub 2016 Nov 21. Review.

PMID:
27872987
30.

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.

Bouchahda M, Boige V, Smith D, Karaboué A, Ducreux M, Hebbar M, Lepère C, Focan C, Guimbaud R, Innominato P, Awad S, Carvalho C, Tumolo S, Truant S, De Baere T, Castaing D, Rougier P, Morère JF, Taieb J, Adam R, Lévi F; ARTBC International.

Eur J Cancer. 2016 Nov;68:163-172. doi: 10.1016/j.ejca.2016.09.011. Epub 2016 Oct 18.

PMID:
27768923
31.

Percutaneous thermal ablation of primary lung cancer.

de Baere T, Tselikas L, Catena V, Buy X, Deschamps F, Palussière J.

Diagn Interv Imaging. 2016 Oct;97(10):1019-1024. doi: 10.1016/j.diii.2016.08.016. Epub 2016 Sep 28. Review.

32.

An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin.

de Baere T, Plotkin S, Yu R, Sutter A, Wu Y, Cruise GM.

J Vasc Interv Radiol. 2016 Sep;27(9):1425-1431. doi: 10.1016/j.jvir.2016.05.015. Epub 2016 Jul 9.

33.

Percutaneous thermal ablation: A new treatment line in the multidisciplinary management of metastatic leiomyosarcoma?

Gravel G, Yevich S, Tselikas L, Mir O, Teriitehau C, De Baère T, Deschamps F.

Eur J Surg Oncol. 2017 Jan;43(1):181-187. doi: 10.1016/j.ejso.2016.06.391. Epub 2016 Jun 22.

PMID:
27371999
34.

Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablation.

Tselikas L, de Baere T, Deschamps F, Hakimé A, Besse B, Teriitehau C, de Montpreville V, Adam J.

Eur Radiol. 2017 Mar;27(3):1211-1217. doi: 10.1007/s00330-016-4447-7. Epub 2016 Jun 14.

PMID:
27300196
35.

Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study.

Berdelou A, Boige V, Arfi-Rouche J, Malka D, Ederhy S, Izzedine H, Leboulleux S, Chougnet CN, Burtin P, De Baere T, Laplanche A, Elias D, Schlumberger M, Scoazec JY, Ducreux M, Baudin E.

Neuroendocrinology. 2017;105(1):26-34. doi: 10.1159/000446988. Epub 2016 May 26.

36.

Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?

de Baere T, Tselikas L, Deschamps F, Boige V, Ducreux M, Hollebecque A.

Hepat Oncol. 2016 Apr;3(2):109-118. doi: 10.2217/hep-2015-0001. Epub 2016 Mar 23. Review.

37.

Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01).

Tacher V, Le Deley MC, Hollebecque A, Deschamps F, Vielh P, Hakime A, Ileana E, Abedi-Ardekani B, Charpy C, Massard C, Rosellini S, Gajda D, Celebic A, Ferté C, Ngo-Camus M, Gouissem S, Koubi-Pick V, Andre F, Vassal G, Deandreis D, Lacroix L, Soria JC, De Baère T.

Eur J Cancer. 2016 May;59:79-89. doi: 10.1016/j.ejca.2016.02.006. Epub 2016 Mar 24.

PMID:
27017289
38.

Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients.

Barral M, Auperin A, Hakime A, Cartier V, Tacher V, Otmezguine Y, Tselikas L, de Baere T, Deschamps F.

Cardiovasc Intervent Radiol. 2016 Jun;39(6):885-93. doi: 10.1007/s00270-016-1301-x. Epub 2016 Feb 9.

PMID:
26860716
39.

Acquired EGFR Mutation as the Potential Resistance Driver to Crizotinib in a MET-Mutated Tumor.

Benderra MA, Aspeslagh S, Postel-Vinay S, Bigot L, De Baere T, Loriot Y, Lacroix L, Massard C, Vassal G, André F, Soria JC.

J Thorac Oncol. 2016 Feb;11(2):e21-3. doi: 10.1016/j.jtho.2015.08.001. Epub 2015 Dec 18. No abstract available.

40.

Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.

Lencioni R, de Baere T, Soulen MC, Rilling WS, Geschwind JF.

Hepatology. 2016 Jul;64(1):106-16. doi: 10.1002/hep.28453. Epub 2016 Mar 7. Review.

PMID:
26765068
41.

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.

Jovelet C, Ileana E, Le Deley MC, Motté N, Rosellini S, Romero A, Lefebvre C, Pedrero M, Pata-Merci N, Droin N, Deloger M, Massard C, Hollebecque A, Ferté C, Boichard A, Postel-Vinay S, Ngo-Camus M, De Baere T, Vielh P, Scoazec JY, Vassal G, Eggermont A, André F, Soria JC, Lacroix L.

Clin Cancer Res. 2016 Jun 15;22(12):2960-8. doi: 10.1158/1078-0432.CCR-15-2470. Epub 2016 Jan 12.

42.

Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective.

Lencioni R, de Baere T, Martin RC, Nutting CW, Narayanan G.

Liver Cancer. 2015 Dec;4(4):208-14. doi: 10.1159/000367747. Epub 2015 Oct 21. Review.

43.

Reply to Dr. Macbeth Letter.

de Baere T, Tselikas L, Callstrom M.

J Thorac Oncol. 2015 Dec;10(12):e121-2. doi: 10.1097/JTO.0000000000000695. No abstract available.

44.

Percutaneous Computed Tomography-Guided Thermal Ablation of Pulmonary Osteosarcoma Metastases in Children.

Yevich S, Gaspar N, Tselikas L, Brugières L, Pacquement H, Schleiermacher G, Tabone MD, Pearson E, Canale S, Muret J, de Baere T, Deschamps F.

Ann Surg Oncol. 2016 Apr;23(4):1380-6. doi: 10.1245/s10434-015-4988-z. Epub 2015 Nov 20.

PMID:
26589502
45.

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.

Lévi FA, Boige V, Hebbar M, Smith D, Lepère C, Focan C, Karaboué A, Guimbaud R, Carvalho C, Tumolo S, Innominato P, Ajavon Y, Truant S, Castaing D, De Baere T, Kunstlinger F, Bouchahda M, Afshar M, Rougier P, Adam R, Ducreux M; Association Internationale pour Recherche sur Temps Biologique et Chronothérapie (ARTBC International).

Ann Oncol. 2016 Feb;27(2):267-74. doi: 10.1093/annonc/mdv548. Epub 2015 Nov 16.

PMID:
26578731
46.

Cone-Beam CT Angiography for Determination of Tumor-Feeding Vessels During Chemoembolization of Liver Tumors: Comparison of Conventional and Dedicated-Software Analysis.

Ronot M, Abdel-Rehim M, Hakimé A, Kuoch V, Roux M, Chiaradia M, Vilgrain V, de Baere T, Deschamps F.

J Vasc Interv Radiol. 2016 Jan;27(1):32-8. doi: 10.1016/j.jvir.2015.09.010. Epub 2015 Nov 6.

PMID:
26549371
47.

Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion.

de Baere T, Arai Y, Lencioni R, Geschwind JF, Rilling W, Salem R, Matsui O, Soulen MC.

Cardiovasc Intervent Radiol. 2016 Mar;39(3):334-43. doi: 10.1007/s00270-015-1208-y. Epub 2015 Sep 21. Review.

PMID:
26390875
48.

Percutaneous osteosynthesis in the pelvis in cancer patients.

Deschamps F, de Baere T, Hakime A, Pearson E, Farouil G, Teriitehau C, Tselikas L.

Eur Radiol. 2016 Jun;26(6):1631-9. doi: 10.1007/s00330-015-3971-1. Epub 2015 Aug 30.

PMID:
26318372
49.

Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis at 1 Year.

de Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F, Suh R, Aoun HD, Callstrom M.

J Thorac Oncol. 2015 Oct;10(10):1468-74. doi: 10.1097/JTO.0000000000000632.

50.

Reply to the letter to the editor 'Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy' by Siva et al.

de Baère T, Aupérin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiére J.

Ann Oncol. 2015 Oct;26(10):2196-7. doi: 10.1093/annonc/mdv301. Epub 2015 Jul 20. No abstract available.

PMID:
26193885

Supplemental Content

Loading ...
Support Center